Ambrx Biopharma American Probability of Future Stock Price Finishing Over 11.69
| AMAMDelisted Stock | USD 15.73 0.71 4.73% |
Ambrx |
Ambrx Biopharma Target Price Odds to finish over 11.69
The tendency of Ambrx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 11.69 in 90 days |
| 15.73 | 90 days | 11.69 | about 84.61 |
Based on a normal probability distribution, the odds of Ambrx Biopharma to stay above $ 11.69 in 90 days from now is about 84.61 (This Ambrx Biopharma American probability density function shows the probability of Ambrx Stock to fall within a particular range of prices over 90 days) . Probability of Ambrx Biopharma American price to stay between $ 11.69 and its current price of $15.73 at the end of the 90-day period is about 68.25 .
Given the investment horizon of 90 days Ambrx Biopharma has a beta of 0.71. This suggests as returns on the market go up, Ambrx Biopharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ambrx Biopharma American will be expected to be much smaller as well. Additionally Ambrx Biopharma American has an alpha of 0.5127, implying that it can generate a 0.51 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ambrx Biopharma Price Density |
| Price |
Predictive Modules for Ambrx Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ambrx Biopharma American. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ambrx Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ambrx Biopharma is not an exception. The market had few large corrections towards the Ambrx Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ambrx Biopharma American, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ambrx Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.51 | |
β | Beta against Dow Jones | 0.71 | |
σ | Overall volatility | 2.02 | |
Ir | Information ratio | 0.09 |
Ambrx Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ambrx Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ambrx Biopharma American can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ambrx Biopharma is not yet fully synchronised with the market data | |
| Ambrx Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.09 M. Net Loss for the year was (67.06 M) with profit before overhead, payroll, taxes, and interest of 7.4 M. | |
| Ambrx Biopharma American currently holds about 110.89 M in cash with (57.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.87. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies |
Ambrx Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ambrx Stock often depends not only on the future outlook of the current and potential Ambrx Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ambrx Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.6 M | |
| Cash And Short Term Investments | 84.5 M |
Ambrx Biopharma Technical Analysis
Ambrx Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ambrx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ambrx Biopharma American. In general, you should focus on analyzing Ambrx Stock price patterns and their correlations with different microeconomic environments and drivers.
Ambrx Biopharma Predictive Forecast Models
Ambrx Biopharma's time-series forecasting models is one of many Ambrx Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ambrx Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ambrx Biopharma American
Checking the ongoing alerts about Ambrx Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ambrx Biopharma American help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ambrx Biopharma is not yet fully synchronised with the market data | |
| Ambrx Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.09 M. Net Loss for the year was (67.06 M) with profit before overhead, payroll, taxes, and interest of 7.4 M. | |
| Ambrx Biopharma American currently holds about 110.89 M in cash with (57.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.87. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Ambrx Stock
If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |